← Back to home
Comparison · Analytics

cfrnow vs epiflows

A side-by-side editorial comparison of cfrnow and epiflows — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:epidemiology

cfrnow vs epiflows: at a glance

Featurecfrnowepiflows
SectorAnalyticsAnalytics
Velocity score5.00.0
Sparks · 30d00
Top themesepidemiology, bayesian-modelling, cfr-estimation, r-packager, epidemiology, dormant, maintenance
Last editorial update7h ago52m ago
WebsiteVisit →Visit →

What is cfrnow?

A Bayesian real-time CFR estimator that now ships stratified fits and posterior-predictive checks

cfrnow estimates case fatality ratios from line-list data while an outbreak is still running, using a Bayesian mixture-cure survival model registered as an `epidist` model type. Three releases in a month took it from first public release to stratified, partially-pooled fits with posterior-predictive checking. It leans on `distspec` for delay parameterisation, which reached CRAN alongside the 0.2.1 patch.

Read the full cfrnow trajectory →

What is epiflows?

epiflows has shipped four releases in eight years, none of which changed the code.

epiflows predicts the spread of infectious disease along population flows between locations, and it is effectively dormant. The whole visible history spans 2018 to 2026 in four entries: the first CRAN release, a Zenodo archival tag, a Roxygen patch whose notes state the functionality is unchanged, and a 2026 release replacing deprecated ggplot2 and tibble calls. No entry describes new epidemiological capability.

Read the full epiflows trajectory →

cfrnow vs epiflows: editorial side-by-side

C
cfrnow
ANALYTICS
5.0

A Bayesian real-time CFR estimator that now ships stratified fits and posterior-predictive checks

◆ Current state

cfrnow estimates case fatality ratios from line-list data while an outbreak is still running, using a Bayesian mixture-cure survival model registered as an `epidist` model type. Three releases in a month took it from first public release to stratified, partially-pooled fits with posterior-predictive checking. It leans on `distspec` for delay parameterisation, which reached CRAN alongside the 0.2.1 patch.

◆ Where it's heading

The arc runs from producing a single corrected CFR number toward supporting a full model-checking workflow. 0.2.0 added the pieces a modeller needs to defend an estimate: replicate line lists replayed through the real-time truncation, an ascertainment-ratio correction for when fatal and non-fatal cases enter the line list at different rates, and per-group CFRs from `brms` formulas. Delay coverage widened from LogNormal and Gamma to Weibull in the same release.

◆ Prediction

Expect the next release to keep widening covariate and pooling support rather than adding new outcome types, since every 0.2.0 addition extended the existing formula interface instead of replacing it.

E
epiflows
ANALYTICS
0.0

epiflows has shipped four releases in eight years, none of which changed the code.

◆ Current state

epiflows predicts the spread of infectious disease along population flows between locations, and it is effectively dormant. The whole visible history spans 2018 to 2026 in four entries: the first CRAN release, a Zenodo archival tag, a Roxygen patch whose notes state the functionality is unchanged, and a 2026 release replacing deprecated ggplot2 and tibble calls. No entry describes new epidemiological capability.

◆ Where it's heading

The package is being kept installable rather than developed. The one recent release is dependency maintenance contributed from outside, which is the pattern for RECON-era epidemiology packages that have outlived their original project funding. Two separate entries are both labelled version 0.2.1, so even the version history is not a reliable guide to what changed.

◆ Prediction

Any further releases will most likely be more deprecation cleanup to keep the package on CRAN; there is nothing in the record suggesting active development has resumed.

Alternatives to cfrnow and epiflows

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either cfrnow or epiflows.

See all cfrnow alternatives → · See all epiflows alternatives →

Recent activity from cfrnow and epiflows

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5d agocfrnowdistspec dependency moves to CRAN
  2. 6d agocfrnowStratified CFR fits, Weibull delays, posterior-predictive checks
  3. 1mo agocfrnowFirst release: real-time CFR from a Bayesian mixture-cure model
  4. 5mo agoepiflowsDeprecated ggplot2 and tibble calls replaced
  5. 3y agoepiflowsRoxygen patch for CRAN checks
  6. 7y agoepiflowsFirst Zenodo archival tag
  7. 8y agoepiflowsFirst CRAN release

Frequently asked questions

What is the difference between cfrnow and epiflows?

Both compete on the same themes — epidemiology — within Analytics. cfrnow is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is cfrnow better than epiflows?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. cfrnow is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to cfrnow?

Top cfrnow alternatives in Analytics are ranked by recent ship velocity. Browse the "cfrnow alternatives" section above for the current picks, or visit /alternatives/cfrnow for the full list with editorial commentary on each.

What are the best alternatives to epiflows?

Top epiflows alternatives in Analytics are ranked by recent ship velocity. Browse the "epiflows alternatives" section above for the current picks, or visit /alternatives/epiflows-r for the full list with editorial commentary on each.